Display options
Cite
Tonin F, Arends IWCE. Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. Beilstein J Org Chem. 2018;14:470-483doi: 10.3762/bjoc.14.33.
Tonin, F., & Arends, I. W. C. E. (2018). Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. Beilstein journal of organic chemistry, 14470-483. https://doi.org/10.3762/bjoc.14.33
Tonin, Fabio, and Arends, Isabel W C E. "Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review." Beilstein journal of organic chemistry vol. 14 (2018): 470-483. doi: https://doi.org/10.3762/bjoc.14.33
Tonin F, Arends IWCE. Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. Beilstein J Org Chem. 2018 Feb 20;14:470-483. doi: 10.3762/bjoc.14.33. eCollection 2018. PMID: 29520309; PMCID: PMC5827811.
Copy Download .nbib Format: NLM
Share it on

Beilstein J Org Chem. 2018 Feb 20;14:470-483. doi: 10.3762/bjoc.14.33. eCollection 2018.

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review.

Beilstein journal of organic chemistry

Fabio Tonin, Isabel W C E Arends

Affiliations

  1. Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands.

PMID: 29520309 PMCID: PMC5827811 DOI: 10.3762/bjoc.14.33

Abstract

Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid (CA), which is the most abundant and least expensive bile acid available. The now available chemical routes for the obtainment of UDCA yield about 30% of final product. For these syntheses several protection and deprotection steps requiring toxic and dangerous reagents have to be performed, leading to the production of a series of waste products. In many cases the cholic acid itself first needs to be prepared from its taurinated and glycilated derivatives in the bile, thus adding to the complexity and multitude of steps involved of the synthetic process. For these reasons, several studies have been performed towards the development of microbial transformations or chemoenzymatic procedures for the synthesis of UDCA starting from CA or chenodeoxycholic acid (CDCA). This promising approach led several research groups to focus their attention on the development of biotransformations with non-pathogenic, easy-to-manage microorganisms, and their enzymes. In particular, the enzymatic reactions involved are selective hydrolysis, epimerization of the hydroxy functions (by oxidation and subsequent reduction) and the specific hydroxylation and dehydroxylation of suitable positions in the steroid rings. In this minireview, we critically analyze the state of the art of the production of UDCA by several chemical, chemoenzymatic and enzymatic routes reported, highlighting the bottlenecks of each production step. Particular attention is placed on the precursors availability as well as the substrate loading in the process. Potential new routes and recent developments are discussed, in particular on the employment of flow-reactors. The latter technology allows to develop processes with shorter reaction times and lower costs for the chemical and enzymatic reactions involved.

Keywords: UDCA; bile acids; biotransformation; hydroxysteroid dehydrogenases; production process

References

  1. Hepatology. 1984 Sep-Oct;4(5 Suppl):66S-71S - PubMed
  2. Biochim Biophys Acta. 1976 Nov 19;450(2):142-53 - PubMed
  3. Gastroenterology. 1989 Jan;96(1):222-9 - PubMed
  4. J Lipid Res. 1987 Jul;28(7):755-9 - PubMed
  5. Appl Microbiol Biotechnol. 2011 Apr;90(1):127-35 - PubMed
  6. Drugs. 1981 Feb;21(2):90-119 - PubMed
  7. J Lipid Res. 1984 Oct;25(10):1084-9 - PubMed
  8. J Lipid Res. 1982 Nov;23(8):1152-8 - PubMed
  9. Appl Microbiol Biotechnol. 2012 Sep;95(5):1221-33 - PubMed
  10. J Lipid Res. 1980 Jan;21(1):72-90 - PubMed
  11. Steroids. 2011 Nov;76(12):1397-9 - PubMed
  12. Semin Liver Dis. 1983 May;3(2):146-56 - PubMed
  13. Biotechnol Bioeng. 2006 Apr 20;93(6):1216-20 - PubMed
  14. Appl Environ Microbiol. 1979 May;37(5):992-1000 - PubMed
  15. Hepatol Res. 2008;38(2):123-31 - PubMed
  16. Steroids. 1997 Aug-Sep;62(8-9):564-77 - PubMed
  17. Gastroenterol Jpn. 1980;15(3):257-63 - PubMed
  18. Eur J Biochem. 1991 Mar 14;196(2):439-50 - PubMed
  19. Curr Microbiol. 2003 Dec;47(6):475-84 - PubMed
  20. Appl Environ Microbiol. 2000 Mar;66(3):1107-13 - PubMed
  21. Steroids. 2008 Dec 22;73(14):1385-90 - PubMed
  22. Prep Biochem. 1982;12(4):307-21 - PubMed
  23. Curr Opin Chem Biol. 2013 Apr;17(2):236-49 - PubMed
  24. Drugs. 1984 Feb;27(2):95-131 - PubMed
  25. J Bacteriol. 1994 Aug;176(16):4865-74 - PubMed
  26. J Biol Chem. 1998 Nov 20;273(47):30888-96 - PubMed
  27. Biochim Biophys Acta. 1978 Jan 27;528(1):148-57 - PubMed
  28. J Pediatr. 1990 Sep;117(3):482-9 - PubMed
  29. Gastroenterology. 1980 Jun;78(6):1412-8 - PubMed
  30. Steroids. 2016 Mar;107:20-9 - PubMed
  31. J Biol Chem. 1952 Apr;195(2):763-78 - PubMed
  32. Dig Dis Sci. 1996 Apr;41(4):809-15 - PubMed
  33. Appl Environ Microbiol. 1982 Nov;44(5):1187-95 - PubMed
  34. J Steroid Biochem. 1984 Oct;21(4):413-20 - PubMed
  35. Steroids. 1997 Apr;62(4):332-45 - PubMed
  36. Biotechnol Bioeng. 2013 Jan;110(1):68-77 - PubMed
  37. Arch Intern Med. 1972 Oct;130(4):506-27 - PubMed
  38. Enzyme Microb Technol. 2017 Apr;99:16-24 - PubMed
  39. Appl Microbiol Biotechnol. 2003 Jan;60(5):495-506 - PubMed
  40. J Bacteriol. 1991 Aug;173(15):4558-69 - PubMed
  41. Hepatology. 1996 Jun;23(6):1484-90 - PubMed
  42. J Biotechnol. 2014 Dec 10;191:11-21 - PubMed
  43. J Ethnobiol Ethnomed. 2009 Jan 12;5:2 - PubMed
  44. Gut Microbes. 2016;7(1):22-39 - PubMed
  45. Arch Intern Med. 1999 Dec 13-27;159(22):2647-58 - PubMed
  46. Chem Rev. 2011 Jul 13;111(7):4111-40 - PubMed
  47. Appl Microbiol Biotechnol. 2013 Jan;97(2):633-9 - PubMed
  48. J Bacteriol. 1991 Apr;173(7):2173-9 - PubMed
  49. Hepatology. 1992 Oct;16(4):924-30 - PubMed
  50. Acta Pathol Microbiol Scand. 1967;71(4):629-38 - PubMed
  51. J Steroid Biochem. 1982 Sep;17(3):295-303 - PubMed
  52. Hepatology. 1982 Nov-Dec;2(6):804-10 - PubMed
  53. J Agric Food Chem. 2017 Feb 15;65(6):1178-1185 - PubMed
  54. Microbiol Res. 2014 Feb-Mar;169(2-3):148-54 - PubMed
  55. Appl Environ Microbiol. 1992 Dec;58(12):3792-8 - PubMed
  56. Nature. 2015 Nov 19;527(7578):394-7 - PubMed
  57. Steroids. 2002 Jan;67(1):51-6 - PubMed
  58. Appl Microbiol Biotechnol. 2012 Sep;95(6):1457-68 - PubMed
  59. N Engl J Med. 1975 Dec 11;293(24):1255-7 - PubMed
  60. J Lipid Res. 1981 Nov;22(8):1225-34 - PubMed
  61. Steroids. 2013 Mar;78(3):370-8 - PubMed
  62. Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45 - PubMed
  63. J Lipid Res. 1982 Jul;23(5):726-32 - PubMed
  64. J Vet Med Sci. 1991 Feb;53(1):81-6 - PubMed
  65. Protein Eng Des Sel. 2007 Jul;20(7):339-46 - PubMed
  66. Appl Environ Microbiol. 1982 Dec;44(6):1249-52 - PubMed
  67. Steroids. 2006 Mar;71(3):189-98 - PubMed
  68. Anaerobe. 2010 Apr;16(2):137-46 - PubMed
  69. J Lipid Res. 2013 Nov;54(11):3062-9 - PubMed

Publication Types